Early supporters
Gavi is grateful to the new and returning donors that have already announced their pledges for Gavi's 2026–2030 strategic period.
- Canada makes pledge of CAD 675 million in new funding for Gavi
Read more
- Indonesia pledges US$ 30 million to support global immunisation efforts through Gavi
Read more
- European Commission pledges new funding of €260 million for the years 2026–2027
Read more
The high-level pledging summit, culminating Gavi’s 6.0 replenishment cycle, will be co-hosted in Brussels by the European Union and the Gates Foundation. The event will bring together global leaders from government, partner organisations, vaccine manufacturers, civil society and the private sector to secure crucial investments in life-saving immunsation programmes.
About the Pledging Summit
Gavi is one of the most successful development initiatives in history, protecting people and communities around the world since 2000. With the launch of Gavi's Investment Opportunity 2026–2030, leaders from government, partner organisations, civil society and business express why immunisation matters.
Hear from our Champions
The Vaccine Alliance plans to accelerate its impact between 2026–2030
leveraging the latest innovations in vaccines and vaccine delivery to protect 500 million children and saving over 8 million lives
Discover our mission
As part of its mission to save lives and protect people’s health by increasing equitable and sustainable use of vaccines, Gavi has helped vaccinate more than 1.1 billion children in 78 lower-income countries, preventing more than 18.8 million future deaths.
Learn more
As part of its mission to save lives and protect people’s health by increasing equitable and sustainable use of vaccines, Gavi has helped vaccinate more than 1.1 billion children in 78 lower-income countries, preventing more than 18.8 million future deaths.
Learn more
Launch of the Investment Opportunity
The Global Forum for Vaccine Sovereignty and Innovation
On 20 June 2024, Gavi co-hosted the Forum alongside the African Union and the French Republic, launching its Investment Opportunity and the African Vaccine Manufacturing Accelerator (AVMA), an innovative financing mechanism which aims to foster regional vaccine production and vaccine sovereignty on the African continent.
Learn more about the Forum
AVMA: what is it and why is it important?
What is the 'Health & Prosperity through Immunisation' Summit and why is it important?
The event will bring together global leaders from government, partner organisations, vaccine manufacturers, civil society and the private sector to secure crucial investments in life-saving immunsation programmes.
A successful replenishment for Gavi will enable the Vaccine Alliance to implement its most impactful strategic period ever. Outcomes, as set out in Gavi’s Investment Opportunity, are expected to include: immunising at least 500 million children; saving an additional 8–9 million lives; generating at least US$ 100 billion in economic benefits for Gavi implementing countries; unprecedented levels of co-financing, with implementing countries contributing US$ 4 billion towards the cost of immunisation programmes; and boosting global health security by responding to 150 disease outbreaks.
When will this event take place?
The event will take place on 25 June 2025, timings to be confirmed in the agenda closer to the event.
Last updated: 24 Apr 2025
